ANGO vs CNC · rev $292.5M vs P/E 8.4, rev $163.07B
AngioDynamics Inc (ANGO) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
ANGO currently screens at market cap $378.5M. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the ANGO and CNC stock pages for the full models.
Not investment advice.